State Street SPDR S&P Biotech ETF (XBI)

State Street SPDR S&P Biotech ETF is trading at $159.22, down 0.20% on the session. The 50 day average sits at $149.95 and the 200 day at $n/a, which puts the stock in a mixed technical position. RSI is at 58.2, which reads as strong, and MACD is bullish crossover. Volume is below average.

The nearest support is around $149.15 with resistance near $165.71, so that band frames the current range. Average daily movement is roughly $3.97, or about 2.5% of the share price, which is what any stop placement has to allow for. The overall health score of 77 out of 100 combines a trend score of 72, momentum of 79 and a risk score of 83.

In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI").